Home/Pipeline/Biocellulose-Based Biomaterials Program

Biocellulose-Based Biomaterials Program

Not Specified ("Untreatable" conditions)

Pre-clinicalActive

Key Facts

Indication
Not Specified ("Untreatable" conditions)
Phase
Pre-clinical
Status
Active
Company

About Biovico

Biovico is a Warsaw-based, private biotechnology and pharmaceutical company with a 15-year history, operating in diagnostics and digital health. It is developing a pipeline of innovative solutions, with a pronounced focus on osteoarthritis and regenerative medicine, utilizing platforms like biocellulose-based biomaterials and hyaluronic acid. The company appears to be in a pre-revenue, research and development stage, aiming to address significant unmet medical needs in joint health and beyond through its paradigm-shifting approach.

View full company profile